Tyr-(Glu1)-Sauvagine is a modified peptide analog featuring N-terminal adjustments that influence binding and conformational behavior. Its sequence is frequently used to explore corticotropin-related peptide motifs. Structural elements support receptor-interaction modeling. Researchers apply it to evaluate analog design principles in neuropeptide families.
CAT No: S2102
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More